Serina Therapeutics's total assets for Q1 2026 were $27.30M, an increase of 292.73% from the previous quarter. SER total liabilities were $9.67M for the fiscal quarter, a 38.39% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.